Skip to main content

Table 5 Comparison of the secondary risk assessment between the two groups

From: Effect of remimazolam besylate on elderly patients with mechanical ventilation: a single-center randomized controlled study

 

Number of times

Control group (N = 22) median (IQR)

Experimental group (N = 27) median (IQR)

Z

P

Spontaneous breathing tolerance evaluation (primary risk assessment)

1

6 (27.30)

9 (33.33)

0.519

0.604

2

7 (31.80)

7 (25.93)

  

3

3 (13.60)

7 (25.93)

  

4

4 (18.20)

2 (7.41)

  

5

1 (4.50)

2 (7.41)

  

Assessment of indications for extubation (Level 2 risk assessment)

1

16 (72.70)

17 (62.96)

0.631

0.528

2

3 (13.60)

6 (22.22)

  

3

3 (13.60)

4 (14.81)

  
  1. Statistical significance was set at P < 0.05